Advertisement

Latest Articles

  • A Commitment to Excellence from the New Editor
    Lynette C. Daws
    Pharmacological Reviews January 2022, 74 (1) 311-312; DOI: https://doi.org/10.1124/pharmrev.121.000534
  • Open Access
    Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
    Hilary Grosso Jasutkar, Stephanie E. Oh and M. Maral Mouradian
    Eric Barker, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 207-237; DOI: https://doi.org/10.1124/pharmrev.120.000133
  • Open Access
    α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials
    Werner Sieghart, Lih-Chu Chiou, Margot Ernst, Jure Fabjan, Miroslav M. Savić and Ming Tatt Lee
    Charles France, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 238-270; DOI: https://doi.org/10.1124/pharmrev.121.000293
  • Neurobiological Mechanisms of Nicotine Reward and Aversion
    Open Access
    Neurobiological Mechanisms of Nicotine Reward and Aversion
    Lauren Wills, Jessica L. Ables, Kevin M. Braunscheidel, Stephanie P.B. Caligiuri, Karim S. Elayouby, Clementine Fillinger, Masago Ishikawa, Janna K. Moen and Paul J. Kenny
    Charles France, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 271-310; DOI: https://doi.org/10.1124/pharmrev.121.000299
  • Open Access
    Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
    Sonia Youhanna, Aurino M. Kemas, Lena Preiss, Yitian Zhou, Joanne X. Shen, Selgin D. Cakal, Francesco S. Paqualini, Sravan K. Goparaju, Reza Zandi Shafagh, Johan Ulrik Lind, Carl M. Sellgren and Volker M. Lauschke
    Gunnar Schulte, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 141-206; DOI: https://doi.org/10.1124/pharmrev.120.000238
  • Inhaled Medicines: Past, Present, and Future
    Open Access
    Inhaled Medicines: Past, Present, and Future
    Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson and Jeffry Weers
    Clive Page, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 48-118; DOI: https://doi.org/10.1124/pharmrev.120.000108
  • The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Open Access
    The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, Richard L. Cullum, Christopher P. Mill, J. Tyler Piazza, Ianthe N. Bryant, Laura J. Cook, S. Tyler Miller, James H. Lott, Connor M. Kelley, Elizabeth L. Knerr, Jessica A. Markham, David P. Kaufmann, Megan A. Jacobi, Jianzhong Shen and David J. Riese
    Eric Barker, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 18-47; DOI: https://doi.org/10.1124/pharmrev.121.000381
  • Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
    Vincent Pons and Serge Rivest
    Robert Dantzer, ASSOCIATE EDITOR, Neuroscience Laboratory, CHU de Québec Research Center and Department of Molecular Medicine, Faculty of Medicine, Laval University, 2705 Laurier Boul., Québec City, QC G1V 4G2, Canada
    Pharmacological Reviews January 2022, 74 (1) 1-17; DOI: https://doi.org/10.1124/pharmrev.121.000400
  • Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
    Céline Nicolas, Natalie E. Zlebnik, Mehdi Farokhnia, Lorenzo Leggio, Satoshi Ikemoto and Yavin Shaham
    Michael Nader, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 119-140; DOI: https://doi.org/10.1124/pharmrev.121.000367
  • Aldo-Keto Reductases and Cancer Drug Resistance
    Open Access
    Aldo-Keto Reductases and Cancer Drug Resistance
    Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
    Michael Gottesman, ASSOCIATE EDITOR
    Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122

Pages